Matthew Harrison

Stock Analyst at Morgan Stanley

(3.47)
# 981
Out of 4,495 analysts
510
Total ratings
48.24%
Success rate
4.41%
Average return

62 Stocks

Insmed
Jul 12, 2024
Maintains: Overweight
Price Target: $60$85
Current: $75.06
Upside: +13.24%
Vertex Pharmaceuticals
Jul 11, 2024
Maintains: Equal-Weight
Price Target: $402$455
Current: $488.12
Upside: -6.79%
Regeneron Pharmaceuticals
Jul 11, 2024
Maintains: Overweight
Price Target: $1,183$1,182
Current: $1,067.26
Upside: +10.75%
Sarepta Therapeutics
Jun 24, 2024
Maintains: Overweight
Price Target: $165$200
Current: $143.78
Upside: +39.10%
Centessa Pharmaceuticals
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8$11
Current: $9.53
Upside: +15.42%
Zentalis Pharmaceuticals
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38$8
Current: $3.95
Upside: +102.53%
argenx SE
May 28, 2024
Maintains: Overweight
Price Target: $515$510
Current: $466.56
Upside: +9.31%
Editas Medicine
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $5.30
Upside: +32.08%
Gilead Sciences
Apr 26, 2024
Maintains: Equal-Weight
Price Target: $80$78
Current: $73.51
Upside: +6.11%
BioMarin Pharmaceutical
Apr 26, 2024
Maintains: Overweight
Price Target: $115$112
Current: $83.34
Upside: +34.39%
Pharvaris
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $18.07
Upside: +88.16%
Genmab
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $27.24
Upside: +17.47%
Biogen
Nov 10, 2023
Maintains: Overweight
Price Target: $361$373
Current: $225.25
Upside: +65.59%
Cerevel Therapeutics Holdings
Nov 2, 2023
Maintains: Overweight
Price Target: $42$38
Current: $42.70
Upside: -11.01%
BeiGene
Aug 29, 2023
Maintains: Overweight
Price Target: $321$319
Current: $152.03
Upside: +109.83%
IO Biotech
Aug 15, 2023
Maintains: Overweight
Price Target: $11$7
Current: $1.37
Upside: +412.82%
Prime Medicine
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21$19
Current: $5.57
Upside: +241.11%
Tenaya Therapeutics
Aug 10, 2023
Maintains: Overweight
Price Target: $13$14
Current: $3.38
Upside: +314.20%
Alector
Aug 7, 2023
Reiterates: Equal-Weight
Price Target: $10
Current: $5.83
Upside: +71.53%
Moderna
Aug 4, 2023
Maintains: Equal-Weight
Price Target: $128$123
Current: $121.32
Upside: +1.38%
2seventy bio
Jul 28, 2023
Downgrades: Equal-Weight
Price Target: $25$13
Current: $4.52
Upside: +187.61%
Legend Biotech
Jul 20, 2023
Maintains: Overweight
Price Target: $65$85
Current: $58.24
Upside: +45.95%
bluebird bio
Jul 11, 2023
Reiterates: Underweight
Price Target: $3
Current: $1.15
Upside: +160.87%
Comcast
Apr 24, 2023
Reiterates: Buy
Price Target: $46
Current: $40.14
Upside: +14.60%
Denali Therapeutics
Apr 12, 2023
Maintains: Overweight
Price Target: $61$63
Current: $21.78
Upside: +189.26%
Vigil Neuroscience
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12$13
Current: $3.77
Upside: +244.83%
Invivyd
Mar 27, 2023
Maintains: Underweight
Price Target: $2$1
Current: $1.22
Upside: -18.03%
Innoviva
Mar 3, 2023
Maintains: Underweight
Price Target: $13$10
Current: $17.11
Upside: -41.55%
Fulcrum Therapeutics
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27$8
Current: $8.12
Upside: -1.48%
Galapagos NV
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57$44
Current: $26.75
Upside: +64.49%
Sana Biotechnology
Jan 24, 2023
Maintains: Overweight
Price Target: $15$13
Current: $5.93
Upside: +119.22%
Lyell Immunopharma
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7$4
Current: $1.63
Upside: +145.40%
Bolt Biotherapeutics
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5$3
Current: $0.74
Upside: +305.41%
BioNTech SE
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203$216
Current: $86.37
Upside: +150.09%
Atea Pharmaceuticals
Jan 24, 2023
Maintains: Underweight
Price Target: $7$4
Current: $3.68
Upside: +8.70%
ADC Therapeutics
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7$5
Current: $3.67
Upside: +36.24%
Adagene
Jan 24, 2023
Maintains: Overweight
Price Target: $7$5
Current: $2.57
Upside: +94.55%
AbbVie
Dec 6, 2022
Maintains: Overweight
Price Target: $178$182
Current: $171.14
Upside: +6.35%
Kodiak Sciences
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12$9
Current: $3.00
Upside: +200.00%
Akero Therapeutics
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30$40
Current: $27.08
Upside: +47.71%
Amgen
Nov 4, 2022
Maintains: Overweight
Price Target: $279$282
Current: $330.97
Upside: -14.80%
Alnylam Pharmaceuticals
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220$210
Current: $236.70
Upside: -11.28%
AlloVir
Sep 9, 2022
Maintains: Overweight
Price Target: $32$27
Current: $0.76
Upside: +3,452.63%
Pfizer
May 4, 2022
Maintains: Equal-Weight
Price Target: $55$52
Current: $29.71
Upside: +75.03%
Johnson & Johnson
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175$173
Current: $155.42
Upside: +11.31%
Sage Therapeutics
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61$57
Current: $12.17
Upside: +368.36%
Ultragenyx Pharmaceutical
Feb 1, 2022
Maintains: Overweight
Price Target: $156$120
Current: $42.78
Upside: +180.50%
Biohaven Pharmaceutical Holding Company
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145$148
Current: $34.71
Upside: +326.39%
Merck & Co.
Nov 29, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $124.25
Upside: -
Bristol-Myers Squibb Company
Oct 12, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $42.39
Upside: -
Taysha Gene Therapies
Aug 18, 2021
Maintains: Overweight
Price Target: n/a
Current: $2.26
Upside: -
Royalty Pharma
Aug 16, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $28.33
Upside: -
Organon & Co.
Aug 16, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $20.97
Upside: -
Eli Lilly
Aug 4, 2021
Maintains: Overweight
Price Target: n/a
Current: $848.90
Upside: -
Grupo Televisa, S.A.B.
Jun 24, 2021
Initiates: Buy
Price Target: n/a
Current: $2.43
Upside: -
REGENXBIO
Mar 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $12.85
Upside: -
Huntington Bancshares
Feb 24, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $14.31
Upside: -
Unity Biotechnology
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $1.47
Upside: -
Evelo Biosciences
May 21, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $0.00
Upside: -
Incyte
Jan 6, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $65.37
Upside: -
Radius Health
Oct 11, 2018
Maintains: Overweight
Price Target: n/a
Current: $17.27
Upside: -
Cytokinetics
Sep 10, 2018
Assumes: Equal-Weight
Price Target: n/a
Current: $55.91
Upside: -